Call for Abstract

In addition to the standard endoscopic procedures, including endoscopic retrograde cholangiopancreatography upper gastrointestinal endoscopy and sigmoidoscopy, UCSF Medical Center's digestive disorder specialists also offer the  advanced endoscopic procedures. And  In many cases, these techniques will  provide improved options for the treatment and diagnosis of a variety of digestive disorders affecting the GI tract.

  • Track 1-1: Stem Cells for Liver Repopulation
  • Track 1-2: Cell Sources, Liver Support Systems and Liver Tissue Engineering
  • Track 1-3: Expansion and Hepatic Differentiation of Adult Blood-Derived CD34+ Progenitor Cells and Promotion of Liver Regeneration After Acute Injury
  • Track 1-4: Expansion and Hepatic Differentiation of Adult Blood-Derived CD34+ Progenitor Cells and Promotion of Liver Regeneration After Acute Injury
  • Track 1-5: Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection
  • Track 1-6: Hepatic Stellate cells as a target for the Treatment for Liver Fibrosis

The classic concept of the gastrointestinal endocrinology is that of a few peptides released for the circulation from endocrine cells, which are interspersed among the other mucosal cells in the upper gastrointestinal tract. Today more than 30 peptide hormone genes are known which are being expressed throughout the digestive tract, which makes the gut the largest endocrine organ in the body. 

  • Track 2-1: A Centenary of Gastrointestinal Endocrinology
  • Track 2-2: Beginnings: A reflection on the History of Gastrointestinal Endocrinology
  • Track 2-3: Gastrointestinal Hormones and their Targets
  • Track 2-4: The Gut as the Largest Endocrine Organ in the Body
  • Track 2-5: Gastrointestinal Hormone Research

Digestive system is a series of hollow organs which are joined in a long, twisting tube. It runs from your mouth to anus and includes your oesophagus, stomach, and small and also large intestines. Your liver, gallbladder and pancreas were also involved. They produce juices which helps digestion

  • Track 3-1: Chest Pain
  • Track 3-2: Gall Stones
  • Track 3-3: Celiac Disease
  • Track 3-4: Crohn’s Disease
  • Track 3-5: Ulcerative Colitis

The routine screening of the blood donors for potentially transmissible infections has been reduced transfusion-associated infection whilst providing an insight into disease prevalence. This retrospective cross-sectional study evaluates the prevalence of the hepatitis B virus (HBV), hepatitis C virus (HCV) and, human immunodeficiency (HIV) and syphilis infection in 2,026,628 potential blood donors screened at Tehran Blood Transfusion Centre. One or the more transmissible infections were identified in 0.52% of the donors with greater prevalence in first time donors

  • Track 4-1: Recent Advances in Liver Stem Cell Therapy
  • Track 4-2: Hepatic Progenitors for Liver Disease
  • Track 4-3: Which Stem Cells for Adult Liver?
  • Track 4-4: The Role of Progenitor Cells in Repair of Liver Injury And In Liver Transplantation
  • Track 4-5: Recent Advances in Pediatric Liver Transplantation

The era that had been began with the fiberoptic endoscope which is called as fibro scope and from there it has been moved to the video scope and more recently to the capsule endoscope and the Extraordinary developments have been  observed in the field of endoscopy over the past 40 years.

  • Track 5-1: Changing Role of Endoscopy in the New Millennium
  • Track 5-2: Future Expectations In Digestive Endoscopy
  • Track 5-3: Optical techniques for the Endoscopic Detection of Dysplastic Colonic Lesions
  • Track 5-4: Colonoscopy, Tumours, and Inflammatory Bowel Disease
  • Track 5-5: Endoscopic Detection of Early Lower Gastrointestinal Cancer

It is a common disorder in the western world which will lead to different complications such as oesophageal stricture and also oesophageal adenocarcinoma. Multiple challenges are associated with the GERD treatment.

  • Track 6-1: Long term management of Gasteroesophageal Reflux Disease and its Complications
  • Track 6-2: pH, Healing Rate, and Symptom Relief in Patients with GERD
  • Track 6-3: Drugs, Bugs, and Oesophageal pH profiles
  • Track 6-4: A Prokinetic approach to treatment of Gastroesophageal Reflux Disease
  • Track 6-5: Lansoprazole in the treatment of Gastro-Oesophageal Reflux Disease in childhood

This includes cancers of the oesophagus, gallbladder, liver, pancreas, stomach, small intestine, bowel (large intestine or colon and rectum), and anus. It is a term for the group of cancers that effect the digestive system

  • Track 7-1: Liver Cancer
  • Track 7-2: Oesophageal Cancer
  • Track 7-3: Pancreatic Cancer
  • Track 7-4: Gallbladder Cancer
  • Track 7-5: Bowel, Small Intestine and Anal cancer

In addition to the  standard endoscopic procedures, including endoscopic retrograde cholangiopancreatography upper gastrointestinal endoscopy and sigmoidoscopy, UCSF Medical Center's digestive disorder specialists also offer the  advanced endoscopic procedures.And  In many cases, these techniques will  provide improved options for the treatment and diagnosis of a variety of digestive disorders affecting the GI tract

  • Track 8-1: Pancreatitis
  • Track 8-2: Pancreatic Cancer
  • Track 8-3: Obesity and Pancreatic Diseases
  • Track 8-4: Nutrition in Pancreatic Disease
  • Track 8-5: Diarrhoea due to Pancreatic Disease

Fibrosis means the formation of an abnormally large amount of scar tissue in the liver .it occurs only when the liver attempts to repair and replace the damaged cells.This involves  autophagy which  refers to the process through which the impaired organelles, misfolded protein, and intruding microorganisms are being degraded by lysosomes to maintain stability in the cells

  • Track 9-1: Treatment of Hepatic Fibrosis
  • Track 9-2: Antifibrotic Therapy in Chronic Liver Disease
  • Track 9-3: Cirrhosis--can we reverse Hepatic fibrosis?
  • Track 9-4: Liver fibrosis: from the bench to clinical targets

Perturbation of the bacterial micro flora from the gastrointestinal (GI) tract may play an important role in the pathophysiology of some of the GI disorders. Probiotics have been used as a treatment for the modality for over a century. They may restore normal bacterial microflora and effect the functioning of the GI tract by a variety of mechanisms. Probiotics are not currently regulated and only few are randomized controlled trials exist investigating their efficacy in the different GI disorders. 

  • Track 10-1: Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders
  • Track 10-2: Gut Microbiota in Obesity and Metabolic Disorders
  • Track 10-3: The place of Probiotics in Human Intestinal Infections
  • Track 10-4: Probiotics, Prebiotics, and Synbiotic
  • Track 10-5: Probiotics in the management of Colonic Disorders

With increase in number of patients and practitioners using CAM modalities, the number of studies on the application of CAM for treatment of GI disorders has been increased. As conventional medical therapies either may not produce satisfactory results or may have side effects, many patients also seek complementary and alternative medicine. Furthermore, patients will prefer additional CAM therapies to improve health-related quality of life through holistic concepts. In the USA, it has been reported around 51% of the patients with GI tract disorders have tried some form of CAM , whereas, in the UK about 26% of the patients with GI tract symptoms and 48% of the patients with irritable bowel syndrome has  been noted to use CAM .

  • Track 11-1: Acupuncture
  • Track 11-2: Moxibustion
  • Track 11-3: Herbal medicine
  • Track 11-4: Nutrition
  • Track 11-5: Chiropractic
  • Track 11-6: Cupping
  • Track 11-7: Massage
  • Track 11-8: Yoga

It is a disease which describes about the ulceration or inflammation in the GI tract and which is usually classified as crohn’s disease or ulcerative colitis. Inflammatory Bowel Diseases  can't be controlled easily and recurrence will be  most challenging issue for the physicians. There are various controlled and colon targeted drug delivery sytems which  are available for the treatment with limited success rate. 

  • Track 12-1: Measurement of Gastrointestinal Sensitivity
  • Track 12-2: Intraluminal pH of the Human Gastrointestinal Tract
  • Track 12-3: Irritable Bowel Syndrome, Anxiety, Depression
  • Track 12-4: Gut feelings about Irritable Syndrome
  • Track 12-5: Cerebral Activation in Irritable Bowel Syndrome

This will  mainly encompasses the study of the brain, the gut, and their interactions with relevance to the understanding and management of the  gastrointestinal motility and the functional gastrointestinal disorders

  • Track 13-1: Clinical Gastroenterology
  • Track 13-2: The Gut as a Neurological Organ
  • Track 13-3: Neuropathy in the Brain-in-the-Gut
  • Track 13-4: The Enteric Nervous System and Neurogasteroenterology
  • Track 13-5: Applied Principles of Neurogasteroenterology:physiology/motility sensation